Indivumed collects and processes solid tumor tissue across all cancer types using our ISO-certified standardized protocol. This innovative and market-leading approach enables research with comparably-processed tissues regardless of whether they are derived from different tumor entities, different patients, or different clinics on the globe.
Together with extremely short ischemia times and standardized sample preparation, we ensure the best quality and, subsequently, the best research data. Our customers benefit from outstanding expertise in tissue collection (together with clinical data procurement), tissue processing, and tissue qualification, performed by our dedicated in-house pathology and data management team. All actions follow the Indivumed Standard Operating Procedure, which adheres to stringent processes to collect and preserve biospecimen. This generates samples that retain patterns of biomolecules such as RNA, DNA, and protein as closely comparable to their state when in the human body as possible.
All Indivumed biobanking procedures follow strict ethical standards. The resulting biospecimen products and clinical data sets cover the complete range of client needs.
Through our extensive biobank and access to viable tissue, Indivumed is able to provide extensive biological tools for cancer research, including tumor tissue already characterized for cancer-relevant mutations, using NGS.
Experienced technicians prepare tissue sections from our high-quality tissue samples. The lab is equipped with up-to-date microtomes and a cryostat, through which we can produce tissue sections from frozen samples (FF) as well formalin-fixed and paraffin-embedded tissues (FFPE) in standard and greater thickness. It is also possible to perform a macrodissection as well as Laser Capture Microdissection (LCM) on our samples.
Indivumed provides primary mixed cultures and cell lines previously established from human tumor tissues. Tissues were obtained fully consented from approved medical centers following strict ethical standards and in accordance with the Indivumed SOP.
- Mutation-characterized cancer tissue
- Cell cultures and cell lines characterized for selected mutations and suitable for validation of experimental results generated with secondary cell lines
- Fresh tissue samples suitable for patient-derived tumor xenograft (PDTX) models
- Comprehensive clinical data available, mutational status on request